The curious case of vacuolar ATPase: regulation of signaling pathways

by Sahithi Pamarthy, Arpita Kulshrestha, Gajendra K. Katara, Kenneth D. Beaman
Published 2018-02-01

Interleukin‐22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer

by Gajendra K. Katara, Arpita Kulshrestha, Sylvia Schneiderman, Valerie Riehl, Safaa Ibrahim, Kenneth D. Beaman
Published 2020-01-01

Cancer‐associated V‐ATPase induces delayed apoptosis of protumorigenic neutrophils

by Safaa A. Ibrahim, Arpita Kulshrestha, Gajendra K. Katara, Valerie Riehl, Manoranjan Sahoo, Kenneth D. Beaman
Published 2020-03-01

Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway

by Arpita Kulshrestha, Gajendra K. Katara, Safaa A. Ibrahim, Valerie Riehl, Manoranjan Sahoo, James Dolan, Kyle W. Meinke, Michael R. Pins, Kenneth D. Beaman
Published 2019-01-01

Corrigendum to “Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway”

by Arpita Kulshrestha, Gajendra K. Katara, Safaa A. Ibrahim, Valerie Riehl, Manoranjan Sahoo, James Dolan, Kyle W. Meinke, Michael R. Pins, Kenneth D. Beaman
Published 2021-01-01

Mammary epithelium‐specific inactivation of V‐ATPase reduces stiffness of extracellular matrix and enhances metastasis of breast cancer

by Gajendra K. Katara, Arpita Kulshrestha, Liqun Mao, Xin Wang, Manoranjan Sahoo, Safaa Ibrahim, Sahithi Pamarthy, Kimiko Suzue, Gajendra S. Shekhawat, Alice Gilman‐Sachs, Kenneth D. Beaman
Published 2018-02-01

In vivo anti‐V‐ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses

by Arpita Kulshrestha, Gajendra K. Katara, Safaa A. Ibrahim, Valerie E. Riehl, Sylvia Schneiderman, Mahmood Bilal, Alexandria N. Young, Shayna Levine, Sara Fleetwood, James Dolan, Alice Gilman‐Sachs, Kenneth D. Beaman
Published 2020-10-01